Finally, in addition to improved anti-tumor efficacy, simultaneous blockade of Dll4/Notch and Ephrin-B2/EphB4 abolished the liver vascular lesions seen when only Dll4/Notch is inhibited [20]. This evidence concerns the gene EPHB4 and neoplasm.